Skip to content

Search

Showing results for "Childhood interstitial lung disease "

New funding supports program to create "happier" parents

New funding from Channel 7 Telethon Trust is allowing ECU researchers to work with ORIGINS families to investigate how parents and their babies can best be supported in the first year.

Virtually More Convenient

ORIGINS is now offering telehealth appointments for the paediatric assessment at the one- and three-year timepoints

COCOON

Assessing the virus transmission, immunity development and wellbeing of families during COVID-19

Timeout for Wellbeing

An experimental study linked to the Mums Minds Matter project, which aims to determine if pregnant women's willingness to engage in online wellbeing programs varies across types.

Preschool ASD & Nutrition

Nutrition in preschool children with autistic behaviours.

Celebrating Elders this NAIDOC Week

Family: Children are a gift, born from country into a family, ancestry and culture as enduring as the universe.

Leading youth mental health researchers welcome sector funding

Leaders of Western Australia’s youth mental health research sector from Embrace at The Kids Research Institute Australia have welcomed the state government’s $420 million boost to mental health spending in its 2023-24 budget.

Youth mental health researchers present at ABC science talk

Youth mental health researchers present at ABC science talk

Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis

Nirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During the 2024 RSV season in Western Australia, 21 922 doses were administered to infants entering their first season and 1221 doses to at-risk children. In this context, the selection and spread of escape variants are a potential concern. This study aimed to investigate nirsevimab binding site mutations using clinical and wastewater data.

Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool

Tools that can be used to collect behavioural data during pandemics are needed to inform policy and practice. The objective of this project was to develop the Your COVID-19 Risk tool in response to the global spread of COVID-19, aiming to promote health behaviour change. We developed an online resource based on key behavioural evidence-based risk factors related to contracting and spreading COVID-19. This tool allows for assessing risk and provides instant support to protect individuals from infection.